RxDoctor Payments Data

Jeffrey Silbiger, MD

Cardiovascular Disease · Elmhurst, NYNPI 1013921782

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $16,600 of the $17,606 with a category attached, or 94.3%. Lantheus Medical Imaging, Inc. accounts for 96.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $9,571 and has fallen 99.2% since, to $79 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,606in general payments, 2019–2025

Across 48 payments — averaging $366.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lantheus Medical Imaging, Inc.$17K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$131
  • Irhythm Technologies, Inc.$83
  • Edwards Lifesciences$74
  • Novartis$68
  • Johnson & Johnson$67
  • plus $162 from 4 others

What the payments were for

  • Speaking & faculty fees$16,60094%
  • Travel & lodging$1151%
  • Food & beverage$8065%
  • Education$850%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,606 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024
$38,909
Medicare patients
467
Services billed
565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Elmhurst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →